Andrology, General and Community Urology (AGC)
The mission of the U-M Division of Andrology, General and Community Urology is to be the national leader in advancing the evaluation and management of prostate cancer early detection, transgender medicine, benign diseases of the prostate, telehealth, male sexual and reproductive systems, all while training the next generation of urologic leaders.
The Division of Andrology, General and Community Urology is the leader, both within Michigan and across the nation, in treatment of benign prostatic hyperplasia, prostate cancer evaluation, treatment of Peyronie's disease, erectile dysfunction and infertility. Our practice sites span the State of Michigan and include locations such as Ann Arbor, Brighton, Chelsea, Livonia and Muskegon.
The Division consists of fifteen urology faculty members, two primary care faculty, two joint faculty members and eight full-time physicians assistants who offer the entire spectrum of male and benign urologic care. The Division serves as the reference center for men seeking the latest treatments for benign prostate enlargement or innovative procedures such as Rezum and HoLEP (Holmium laser enucleation of the prostate). AGC was also the first to offer injections for Peyronie's disease along with other groundbreaking treatments for male sexual and reproductive concerns.